Friday - July 17, 2026
New FDA Plausible Mechanism Framework Spurs Development of Personalized In Vivo Prime Editing Platform for Urea Cycle Disorders
March 31, 2026
PHILADELPHIA, Pennsylvania, March 31 [Category: BizHospital] -- Children's Hospital of Philadelphia issued the following news release:

* * *

New FDA Plausible Mechanism Framework Spurs Development of Personalized In Vivo Prime Editing Platform for Urea Cycle Disorders

*

Researchers from Children's Hospital of Philadelphia (CHOP) and Penn Medicine, along with collaborating institutions, reported results today supporting a customizable . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products

Click here for more information about our products